These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25582346)

  • 1. The prognostic value of phosphorylated Akt in breast cancer: a systematic review.
    Yang ZY; Di MY; Yuan JQ; Shen WX; Zheng DY; Chen JZ; Mao C; Tang JL
    Sci Rep; 2015 Jan; 5():7758. PubMed ID: 25582346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients.
    Tokunaga E; Kimura Y; Oki E; Ueda N; Futatsugi M; Mashino K; Yamamoto M; Ikebe M; Kakeji Y; Baba H; Maehara Y
    Int J Cancer; 2006 Jan; 118(2):284-9. PubMed ID: 16049961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.
    Zheng Q; Xia W; Lu Q; Hong R; Qin G; Xu F; Qin T; Shi Y; Yuan Z; Wang S
    Breast Cancer Res Treat; 2016 Nov; 160(2):197-209. PubMed ID: 27663434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.
    Wang J; Zhang C; Chen K; Tang H; Tang J; Song C; Xie X
    Breast Cancer Res Treat; 2015 Jul; 152(2):255-69. PubMed ID: 26070269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1.
    Ueda S; Tsuda H; Sato K; Takeuchi H; Shigekawa T; Matsubara O; Hiraide H; Mochizuki H
    Cancer Sci; 2006 Jul; 97(7):597-604. PubMed ID: 16827799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
    Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
    Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer.
    Magkou C; Mylona E; Theohari I; Giannopoulou I; Papanikolaou E; Markaki S; Nakopoulou L
    In Vivo; 2007; 21(6):967-72. PubMed ID: 18210742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
    Lahart IM; Metsios GS; Nevill AM; Carmichael AR
    Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
    Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
    Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.
    Tokunaga E; Kataoka A; Kimura Y; Oki E; Mashino K; Nishida K; Koga T; Morita M; Kakeji Y; Baba H; Ohno S; Maehara Y
    Eur J Cancer; 2006 Mar; 42(5):629-35. PubMed ID: 16464571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of phosphatase and tensin homolog negativity in breast cancer: A systematic review and meta-analysis of 32 studies with 4393 patients.
    Yang ZY; Yu YY; Yuan JQ; Shen WX; Zheng DY; Chen JZ; Mao C; Tang JL
    Crit Rev Oncol Hematol; 2016 May; 101():40-9. PubMed ID: 26951995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer.
    Wennemers M; Stegeman H; Bussink J; Versleijen-Jonkers YM; van Laarhoven HW; Raleigh JA; Varia MA; Sweep FC; Span PN
    Int J Biol Markers; 2013 Jun; 28(2):151-60. PubMed ID: 23558942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
    Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
    Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An automated epifluorescence microscopy imaging assay for the identification of phospho-AKT level modulators in breast cancer cells.
    Kaemmerer E; Turner D; Peters AA; Roberts-Thomson SJ; Monteith GR
    J Pharmacol Toxicol Methods; 2018; 92():13-19. PubMed ID: 29438745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.